CIK 0001661998
- Non-accelerated filer
- Smaller reporting company
Q32 Bio Inc.
Sign in to watch- Ticker
- QTTB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473468154
- Phone
- +1 781-999-0232
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Former names
- Q32 Bio Inc., Homology Medicines, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $320,396
- in 6 filings
Net −$320,396. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-15 | Thistle Mary Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2022-06-15 | Gregory Richard J. Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2022-06-15 | Poulton Jeffrey V. Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2022-06-15 | REICIN ALISE Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2022-06-15 | PARMAR KUSH Director | Grant or award · Option (Right to Buy) | +18,000 | 18,000 | ||
| 2022-04-21 | Seymour Albert | Grant or award · Employee Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2022-02-24 | Smith W Bradford CFO & Treasurer | Grant or award · Employee Stock Option (Right to Buy) | +126,000 | 126,000 | ||
| 2022-02-24 | Smith W Bradford CFO & Treasurer | Grant or award · Restricted Stock Units | +21,000 | 21,000 | ||
| 2022-02-24 | Kelly Timothy P Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +28,200 | 28,200 | ||
| 2022-02-24 | Kelly Timothy P Chief Operating Officer | Grant or award · Restricted Stock Units | +4,800 | 4,800 | ||
| 2022-02-24 | Seymour Albert Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +128,000 | 128,000 | ||
| 2022-02-24 | Seymour Albert Chief Scientific Officer | Grant or award · Restricted Stock Units | +21,000 | 21,000 | ||
| 2022-02-24 | TZIANABOS ARTHUR President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2022-02-24 | TZIANABOS ARTHUR President & CEO | Grant or award · Restricted Stock Units | +58,000 | 58,000 | ||
| 2022-01-05 | Smith W Bradford CFO & Treasurer | Sale | −2,182 | $3.78 | $8K | 4,418 |
| 2022-01-05 | Kelly Timothy P Chief Operating Officer | Sale | −1,406 | $3.78 | $5K | 2,224 |
| 2022-01-05 | Seymour Albert Chief Scientific Officer | Sale | −1,661 | $3.78 | $6K | 131,646 |
| 2022-01-05 | Cohn Gabriel Chief Medical Officer | Sale | −1,661 | $3.78 | $6K | 2,629 |
| 2022-01-05 | TZIANABOS ARTHUR President & CEO | Sale | −5,354 | $3.78 | $20K | 86,011 |
| 2022-01-01 | Smith W Bradford CFO & Treasurer | Exercise or conversion | +6,600 | 6,600 |
Page 13 of 25 · 492 trades